CHARLES RIVER LABORATORIES (CRL) Earnings History & Surprises

NYSE:CRL • US1598641074

Current stock price

155.46 USD
+2.8 (+1.83%)
At close:
155.46 USD
0 (0%)
After Hours:

CRL Earnings overview

Past quarterly earnings results for CHARLES RIVER LABORATORIES (CRL), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
$1.95
Revenue Estimate
990.11M

Last Reported

Most Recent
Release Date
Feb 18, 2026
Period
Q4 / 2025
EPS Reported
$2.39
EPS Surprise
0.98%
Revenue Surprise
-0.27%

Beat Rate

Last 8 Quarters
88%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q4 2025 2.39 2.37 0.98% -10.15% 994.227M 996.87M -0.27% -0.83%
Q3 2025 2.43 2.36 2.88% -6.18% 1.005B 1.001B 0.38% -0.49%
Q2 2025 3.12 2.52 23.68% 11.43% 1.032B 994.91M 3.74% 0.59%
Q1 2025 2.34 2.10 11.44% 3.08% 984.168M 951.39M 3.45% -2.71%
Q4 2024 2.66 2.56 4.03% 8.13% 1.003B 993.46M 0.91% -1.08%
Q3 2024 2.59 2.45 5.70% -4.78% 1.01B 985.77M 2.43% -1.64%
Q2 2024 2.80 2.42 15.80% 4.09% 1.026B 1.035B -0.86% -3.19%
Q1 2024 2.27 2.09 8.63% -18.35% 1.012B 1.002B 0.95% -1.73%
Q4 2023 2.46 2.43 1.38% -17.45% 1.013B 1.001B 1.25% -7.85%
Q3 2023 2.72 2.39 13.71% 3.42% 1.027B 1.011B 1.55% 3.79%
Q2 2023 2.69 2.66 0.95% -2.89% 1.06B 1.064B -0.38% 8.92%
Q1 2023 2.78 2.61 6.34% 1.09% 1.029B 996.21M 3.33% 12.63%
Q4 2022 2.98 2.77 7.46% 19.68% 1.1B 1.045B 5.25% 21.52%
Q3 2022 2.63 2.52 4.37% -2.59% 989.157M 980.14M 0.92% 10.40%
Q2 2022 2.77 2.76 0.30% 6.13% 973.131M 1.005B -3.17% 6.40%
Q1 2022 2.75 2.74 0.26% 8.70% 913.929M 919.21M -0.57% 10.83%
Q4 2021 2.49 2.46 1.35% 4.18% 905.05M 897.16M 0.88% 14.42%
Q3 2021 2.70 2.60 3.70% 15.88% 895.937M 912.23M -1.79% 20.54%
Q2 2021 2.61 2.40 8.57% 65.19% 914.607M 889.25M 2.85% 33.99%
Q1 2021 2.53 2.21 14.27% 37.50% 824.6M 806.16M 2.29% 16.62%
Q4 2020 2.39 2.13 12.40% - 791M 764.43M 3.48% -
Q3 2020 2.33 1.82 28.20% - 743.3M 724.05M 2.66% -
Q2 2020 1.58 1.28 23.72% - 682.6M 645.71M 5.71% -
Q1 2020 1.84 1.50 22.89% - 707.1M 697.6M 1.36% -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

CRL EPS Q2Q GrowthCRL EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q3/21 Q1/22 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 Q1/26 Q3/26 Q1/27 Q3/27 0 20 40 60

Revenue Historical Q2Q growth and Acceleration

CRL Revenue Q2Q GrowthCRL Revenue Q2Q GrowthRevenue Q2Q Growth Q1/21 Q3/21 Q1/22 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 Q1/26 Q3/26 Q1/27 Q3/27 0 10 20 30

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
4
Average EPS beat (4)
9.75%
Max EPS beat (4)
23.68%
Min EPS beat (4)
0.98%

Revenue beat statistics

Revenue beat (4)
3
Average Revenue beat (4)
1.83%
Max Revenue beat (4)
3.74%
Min Revenue beat (4)
-0.27%

Analysis

In the last 4 quarters, CRL has consistently beaten EPS estimates in all releases
CRL has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, CRL has beaten the EPS estimates by 9.7% on average.
In the last 4 quarters, CRL has beaten the revenue estimates by 1.8% on average.
CRL Overview CRL Technical Analysis Report CRL Fundamental Analysis Report CRL Forecast & Price Target
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

CHARLES RIVER LABORATORIES / CRL Earnings FAQ

What is the most recent earnings date for CRL stock?

CHARLES RIVER LABORATORIES (CRL) last reported earnings on 2/18/2026.

Did CHARLES RIVER LABORATORIES (CRL) beat earnings estimates last quarter?

CHARLES RIVER LABORATORIES (CRL) beat EPS estimates and missed revenue estimates in the most recent quarter.

How often does CHARLES RIVER LABORATORIES (CRL) beat earnings estimates?

In the last 4 quarters, CHARLES RIVER LABORATORIES (CRL) has beaten EPS estimates in 4 out of 4 releases.